Dover Corporation (DOV)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	24,297	25,737	21,517	19,005	26,148	18,193
Market Cap Growth	1.30%	19.62%	13.21%	-27.32%	43.72%	8.66%
Enterprise Value	25,998	28,738	24,384	22,331	28,469	20,903
Last Close Price	176.10	186.57	151.26	131.28	173.51	119.06
PE Ratio	10.68	9.54	20.36	17.84	23.27	26.62
Forward PE	17.76	20.71	16.35	15.37	22.92	21.15
PS Ratio	3.09	3.32	2.80	2.42	3.31	2.72
PB Ratio	3.25	3.70	4.21	4.43	6.24	5.37
P/TBV Ratio	141.87	55.06	-	-	-	-
P/FCF Ratio	44.24	44.31	18.66	31.96	27.69	19.37
P/OCF Ratio	32.36	34.39	16.10	23.59	23.43	16.47
PEG Ratio	1.70	2.37	1.43	1.40	1.75	1.81
EV/Sales Ratio	3.32	3.71	3.17	2.85	3.60	3.13
EV/EBITDA Ratio	15.17	17.64	15.47	13.85	17.78	16.55
EV/EBIT Ratio	19.14	22.26	19.18	16.95	21.72	21.25
EV/FCF Ratio	47.54	49.48	21.15	37.55	30.15	22.26
Debt / Equity Ratio	0.41	0.46	0.72	0.91	0.79	0.98
Debt / EBITDA Ratio	1.70	1.84	2.22	2.30	1.97	2.46
Debt / FCF Ratio	5.61	5.45	3.20	6.55	3.51	3.52
Asset Turnover	0.64	0.65	0.69	0.74	0.81	0.75
Inventory Turnover	3.71	4.15	3.82	3.86	4.86	5.11
Quick Ratio	1.27	1.47	0.72	0.69	0.78	0.96
Current Ratio	1.95	2.04	1.41	1.23	1.36	1.51
Return on Equity (ROE)	16.72%	23.22%	20.10%	23.36%	29.67%	21.30%
Return on Assets (ROA)	6.94%	6.76%	7.14%	7.73%	8.38%	6.90%
Return on Capital (ROIC)	8.91%	8.53%	9.36%	10.50%	11.55%	9.49%
Return on Capital Employed (ROCE)	12.40%	12.50%	14.20%	16.20%	16.10%	13.30%
Earnings Yield	9.48%	10.48%	4.91%	5.61%	4.30%	3.76%
FCF Yield	2.26%	2.26%	5.36%	3.13%	3.61%	5.16%
Dividend Yield	1.16%	1.10%	1.34%	1.53%	1.15%	1.65%
Payout Ratio	12.42%	10.50%	26.90%	26.99%	25.53%	41.60%
Buyback Yield / Dilution	1.20%	1.35%	2.09%	1.16%	0.08%	1.09%
Total Shareholder Return	2.37%	2.45%	3.43%	2.69%	1.23%	2.74%

Updated Jul 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q